Connect with others who understand.

sign up log in
About MyPsoriasisTeam
PSORIASIS
NEWS

Psoriasis and Alzheimer’s Disease Are Linked By Chronic Inflammation and Genetics

Posted on December 30, 2021
See how 367 members reacted on this article
Medically reviewed by
Ariel D. Teitel, M.D., M.B.A.
Article written by
Emily Wagner, M.S.

  • A recent review of several existing studies highlights how inflammation is related to both Alzheimer’s disease and skin diseases, like psoriasis.
  • Inflammation caused by shared cytokines — such as TNF-alpha — is involved in both diseases, possibly linking them to each other.
  • People with psoriasis are at a higher risk of developing dementia, and vice versa, but researchers noted there is no precise correlation.

A recent review of existing studies highlights the relationship between Alzheimer’s disease and skin diseases — including psoriasis, skin cancer, and hidradenitis suppurativa. Researchers found that inflammation acts as a driver in all of these diseases, connecting them.

Dementia is a neurological disorder that affects 50 million people worldwide, particularly people of older age. Alzheimer’s disease is the most common subtype of dementia, accounting for about 44 percent of all cases.

Several studies have investigated the relationship between Alzheimer’s disease and skin diseases. The authors of this review set out to summarize the findings so that neurologists and dermatologists are fully informed.

Inflammation as a Driver of Alzheimer’s Disease and Psoriasis

Psoriasis is a chronic inflammatory skin condition that causes scaly plaques to form. It affects 125 million people around the world — and 8 million people in the United States alone. While the main effects of the disease appear on the skin, psoriasis is also associated with other complications, such as mental disorders, cardiovascular disease, and other immunological diseases.

The connection between dementia and psoriasis has been previously studied, and while the exact link is not known, researchers believe inflammation is to blame. In psoriasis, inflammatory mediators known as cytokines are responsible for activating the immune system. Some of these cytokines are shared between psoriasis and Alzheimer’s disease, connecting them through inflammation.

One cytokine — tumor necrosis factor alpha (TNF-alpha) — is known to play a role in both diseases. Treating psoriasis with TNF inhibitors — biologics that block TNF-alpha — improves skin disease. These medications also improve cognitive function in Alzheimer’s disease. In fact, one study found that treating people with psoriasis with TNF-alpha blockers lowered their risk of developing Alzheimer’s disease compared to those who did not receive the treatment.

The Role of Genetics

Genetics may also play a role in the connection between the two diseases. One protein — apolipoprotein E (APOE) — is known to be strongly associated with Alzheimer’s disease and can also be a risk factor for psoriasis.

APOE acts as a cholesterol carrier, which affects the formation of plaques that form on the brain in Alzheimer’s disease. A large study of people with psoriasis and those without found that certain versions of the APOE gene influence the risk of developing the skin disease. This connection potentially links the two diseases.

Risks of Developing Psoriasis and Alzheimer’s Disease

Research has found that people with psoriasis are 10 percent to 25 percent more likely to develop dementia. Researchers also have found that those with dementia have an increased risk of developing psoriasis. However, one study did find that having psoriasis protects against dementia.

The review authors also noted that studies have found that people with psoriasis are at a higher risk for developing issues concentrating, solving problems, and remembering information — all signs of early dementia. Although there is an increased risk of developing psoriasis and Alzheimer’s disease, the authors note that there is not an exact correlation. More research is needed to confirm this relationship.

Ariel D. Teitel, M.D., M.B.A. is the clinical associate professor of medicine at the NYU Langone Medical Center in New York. Review provided by VeriMed Healthcare Network. Learn more about him here.
Emily Wagner, M.S. holds a Master of Science in biomedical sciences with a focus in pharmacology. She is passionate about immunology, cancer biology, and molecular biology. Learn more about her here.

Recent news

The U.S. Food and Drug Administration (FDA) recently approved a new use for Otezla (apremilast)...
Posted 01/12/2022

Otezla Now Approved for All Severity Levels of Psoriasis

The U.S. Food and Drug Administration (FDA) recently approved a new use for Otezla (apremilast)...
Posted 01/12/2022
Research shows that individuals with psoriasis or psoriatic arthritis (PsA) are more likely to...
Posted 01/11/2022

Sexual Dysfunction and Depression Rates Are Higher Among People With Psoriasis and PsA, Study Finds

Research shows that individuals with psoriasis or psoriatic arthritis (PsA) are more likely to...
Posted 01/11/2022
On a recent podcast, representatives of the National Psoriasis Foundation (NPF) and Hemophilia...
Posted 01/05/2022

Critics of Step Therapy Warn It May Lead to Worse Health Outcomes

On a recent podcast, representatives of the National Psoriasis Foundation (NPF) and Hemophilia...
Posted 01/05/2022
Lately I have been wondering about my biological treatment for psoriasis and when (if ever) to...
Posted 01/04/2022

Can I Ever Stop Taking My Biologic for Psoriasis?

Lately I have been wondering about my biological treatment for psoriasis and when (if ever) to...
Posted 01/04/2022
The Society for Pediatric Dermatology has released a virtual handout about psoriasis for...
Posted 12/29/2021

Nonprofit Releases Guides for Teachers and Nurses To Support Students With Skin Conditions

The Society for Pediatric Dermatology has released a virtual handout about psoriasis for...
Posted 12/29/2021
A recent study found that people with psoriasis would like their health care providers to use a “...
Posted 12/28/2021

Individuals With Psoriasis Would Prefer ‘Biologic Calculator’ To Help Guide Treatment Decisions

A recent study found that people with psoriasis would like their health care providers to use a “...
Posted 12/28/2021
Tumor necrosis factor (TNF) inhibitors — a type of biologic — are effective treatments for...
Posted 12/24/2021

Serious Infection Risks Lower for People With Psoriatic Arthritis Than Rheumatoid Arthritis After TNF Inhibitor Treatment

Tumor necrosis factor (TNF) inhibitors — a type of biologic — are effective treatments for...
Posted 12/24/2021
Women with psoriatic arthritis (PsA) face higher risks during pregnancy, including greater...
Posted 12/22/2021

Women With Psoriatic Arthritis Face More Risks During Pregnancy

Women with psoriatic arthritis (PsA) face higher risks during pregnancy, including greater...
Posted 12/22/2021
I had anxiety and depression long before I first experienced psoriasis. They are an expected part...
Posted 12/21/2021

The Relationship Between My Anxiety and Psoriasis

I had anxiety and depression long before I first experienced psoriasis. They are an expected part...
Posted 12/21/2021
People with psoriasis who take immunosuppressant drugs develop normal levels of antibodies from a...
Posted 12/17/2021

Immunosuppressants for Psoriasis May Reduce Effectiveness of COVID-19 Vaccine, Study Finds

People with psoriasis who take immunosuppressant drugs develop normal levels of antibodies from a...
Posted 12/17/2021
psoriasis News

Become a Subscriber

Get the latest news about psoriasis sent to your inbox.

Not now, thanks

Privacy policy
psoriasis News

Thank you for signing up.

close